Critical Limb Ischemia Clinical Trials

22 recruiting

Frequently Asked Questions

Common questions about Critical Limb Ischemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Early Phase 1

Nutrition in Patient With Critical Limb Ischemia

MalnutritionNutritional SupplementsCritical Limb Ischemia
Boston Medical Center30 enrolled1 locationNCT03529019
Recruiting

CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

ClaudicationPeripheral Arterial DiseaseFemoral Arterial Calcification+1 more
Yale University50 enrolled2 locationsNCT05145478
Recruiting
Phase 4

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

Buerger's DiseaseCritical Limb Ischemia
Cell Biopeutics Resources Sdn Bhd3 enrolled1 locationNCT05854615
Recruiting
Phase 4

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease

Peripheral Arterial DiseaseCritical Limb Ischemia
Cell Biopeutics Resources Sdn Bhd10 enrolled1 locationNCT05854641
Recruiting
Phase 3

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Peripheral Artery DiseaseCritical Limb Ischemia
Mercator MedSystems, Inc.250 enrolled2 locationsNCT04433572
Recruiting
Not Applicable

Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery

Critical Limb Ischemia (CLI)
Stentit10 enrolled1 locationNCT07006467
Recruiting

Pressure (Fractional Flow Reserve) and Flow (Vascular Flow Reserve) Measurements During Peripheral Arterial Interventions

Peripheral Arterial DiseaseCritical Limb Ischemia (CLI)
Dr. Konstantinos Katsanos100 enrolled1 locationNCT07052435
Recruiting
Not Applicable

Serrantor OCT Study

Critical Limb Ischemia
Cagent Vascular LLC60 enrolled2 locationsNCT06434194
Recruiting

Use of Thermal Imaging Camera to Assess Perfusion Before and After Vascular Intervention

Peripheral Arterial DiseaseCritical Lower Limb IschemiaCritical Limb Ischemia
University Hospitals Cleveland Medical Center25 enrolled3 locationsNCT06544135
Recruiting

miRNAs in Critical Limb Ischemia (miRNACLI)

Critical Limb Ischemia
IRCCS Policlinico S. Donato80 enrolled1 locationNCT06066268
Recruiting
Phase 2

TP03HN106 in Patients With Critical Limb Ischemia

Critical Limb Ischemia
Talengen Institute of Life Sciences, Shenzhen, P.R. China.15 enrolled1 locationNCT06482892
Recruiting
Not Applicable

MOTIV BTK Randomized Controlled Trial

Critical Limb Ischemia
REVA Medical, Inc.292 enrolled4 locationsNCT05406622
Recruiting
Not Applicable

FAZA PET/MRI in CLI Patients Pre and Post Revascularization

Critical Limb Ischemia
University Health Network, Toronto40 enrolled1 locationNCT04054609
Recruiting
Not Applicable

Additional Hyperbaric Oxygen After Lower Extremity Amputation

OsteomyelitisDiabetes MellitusAmputation+6 more
Oslo University Hospital120 enrolled2 locationsNCT03594344
Recruiting

Acceleration Time Assessment for Prediction of Critical Limb Ischemia

Critical Limb Ischemia
Centre Hospitalier le Mans431 enrolled3 locationsNCT06296576
Recruiting
Phase 3

Trial to Assess Chelation Therapy in Critical Limb Ischemia

DiabetesCritical Limb Ischemia
Mt. Sinai Medical Center, Miami50 enrolled1 locationNCT03982693
Recruiting
Not Applicable

PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

Critical Limb Ischemia
LimFlow, Inc.100 enrolled30 locationsNCT05313165
Recruiting
Not Applicable

Evaluation of the MAGNITUDE® Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia

Critical Lower Limb IschemiaCritical Limb-Threatening IschemiaCritical Limb Ischemia
R3 Vascular Inc.30 enrolled1 locationNCT06075940
Recruiting
Phase 1

Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia

Critical Limb Ischemia
Allife Medical Science and Technology Co., Ltd.27 enrolled1 locationNCT06359912
Recruiting
Early Phase 1

Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy

Critical Limb Ischemia
Nanjing University40 enrolled1 locationNCT06174597